The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer

The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer

Colorectal cancer (CRC) is the third most common cancer worldwide, ranking as high as the second leading cause of cancer-related deaths in industrialized countries. Consistent with immunosurveillance theory, the immune system is crucial to protect the host from developing tumors, and the major playe...

Full description

Bibliographic Details
Main Authors:	Elena Niccolai, Federica Ricci, Edda Russo, Giulia Nannini, Giacomo Emmi, Antonio Taddei, Maria Novella Ringressi, Filippo Melli, Manouela Miloeva, Fabio Cianchi, Paolo Bechi, Domenico Prisco, Amedeo Amedei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-12-01
Series:	Frontiers in Immunology
Subjects:	colorectal cancer tumor-infiltrating lymphocytes regulatory T cells not effector T cells T helper tumor microenvironment
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01900/full

Similar Items

An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment
by: Leena Halim, et al.
Published: (2017-07-01)

Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation—Lessons From Rheumatoid Arthritis
by: Karine Chemin, et al.
Published: (2019-03-01)

The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer
by: Elena Niccolai, et al.
Published: (2017-10-01)

Distinct Roles of Vav Family Members in Adaptive and Innate Immune Models of Arthritis
by: Javier Conde, et al.
Published: (2021-06-01)

Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
by: Sonja Lieber, et al.
Published: (2018-05-01)

Differential Responses of Colorectal Cancer Cell Lines to <em>Enterococcus faecalis’</em> Strains Isolated from Healthy Donors and Colorectal Cancer Patients
by: Carolina Vieira De Almeida, et al.
Published: (2019-03-01)

Effects of pregnancy-specific β-1-glycoprotein on the helper T-cell response
by: Timganova Valeria, et al.
Published: (2019-01-01)

Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
by: Mario Milco D’Elios, et al.
Published: (2012-10-01)

The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells
by: Lin-Lin Ye, et al.
Published: (2018-03-01)

Lineage Reprogramming of Effector Regulatory T Cells in Cancer
by: Michael L. Dixon, et al.
Published: (2021-07-01)

Carbonic Anhydrase Inhibitor Acetazolamide Enhances CHOP Treatment Response and Stimulates Effector T-Cell Infiltration in A20/BalbC Murine B-Cell Lymphoma
by: Gábor Méhes, et al.
Published: (2020-07-01)

Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
by: Nicola Principe, et al.
Published: (2020-11-01)

A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics
by: Prathyaya Ramesh, et al.
Published: (2021-02-01)

Editorial: Novel Strategies for Anti-Tumor Vaccines
by: Roberto S. Accolla, et al.
Published: (2020-01-01)

Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: a critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state
by: Roberto eAccolla, et al.
Published: (2014-02-01)

Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice
by: Xiaoning Zhang, et al.
Published: (2018-09-01)

Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function
by: Saeed Daneshmandi, et al.
Published: (2021-03-01)

MiR-206 regulates the Th17/Treg ratio during osteoarthritis
by: Xiguang Ye, et al.
Published: (2021-06-01)

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
by: Jeanne Galaine, et al.
Published: (2015-06-01)

Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines
by: Accolla Roberto S, et al.
Published: (2012-07-01)

Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
by: Elodie Renaude, et al.
Published: (2021-06-01)

Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study
by: Edda Russo, et al.
Published: (2018-01-01)

The correlation between the Th17/Treg cell balance and bone health
by: Lei Zhu, et al.
Published: (2020-10-01)

Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
by: Christoph Stein, et al.
Published: (2012-06-01)

The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation
by: Agnieszka M Kabat, et al.
Published: (2016-02-01)

Differentiation of naive human CD4 T cells into TH2/TH1 effectors
by: Guy Delespesse, et al.
Published: (1997-01-01)

Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients
by: Serena De Matteis, et al.
Published: (2018-06-01)

A Poplar Rust Effector Protein Associates with Protein Disulfide Isomerase and Enhances Plant Susceptibility
by: Mst Hur Madina, et al.
Published: (2020-09-01)

Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α–TNF Receptor-2 Pathway
by: Min Wang, et al.
Published: (2018-06-01)

Methods to Illuminate the Role of Salmonella Effector Proteins during Infection: A Review
by: Alexandra M. Young, et al.
Published: (2017-08-01)

Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients
by: Dao Huy Manh, et al.
Published: (2020-09-01)

Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer
by: Elena Niccolai, et al.
Published: (2021-01-01)

Tissue specific heterogeneity in effector immune cell response
by: Saba eTufail, et al.
Published: (2013-08-01)

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells
by: Farah Bou Nasser Eddine, et al.
Published: (2017-11-01)

IMPROVING DRUG UPTAKE AND PENETRATION INTO TUMORS: CURRENT AND FORTHCOMING OPPORTUNITIES.
by: Fabrizio eMarcucci, et al.
Published: (2013-06-01)

Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome
by: A Jaiswal, et al.
Published: (2014-01-01)

Alterations of CD4+T Cell Subsets in Blood and Peritoneal Fluid in Different Stages of Endometriosis
by: Fatemeh Pashizeh, et al.
Published: (2020-10-01)

Assessment of Treg and Th17 contents in peripheral blood of patients with non-small cell lung cancer and analysis of their correlation with clinicopathologic characteristics
by: Jin Pu, et al.
Published: (2016-06-01)

Primary Melanoma tumor immune contexture analysis: T regulatory cell to T effector cell ratio as related to MHC class II and GILT expression
by: Cole, Lauren
Published: (2017)

Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
by: Brandon Douglas Brown, et al.
Published: (2021-03-01)